Do not let the AI tool define the strategy.
Independent evaluation for leadership teams considering Copilot, ChatGPT Enterprise, CRM AI, document automation, workflow tools or sector-specific AI platforms.
The decision this helps you make
Should we buy, delay, negotiate, replace, or reject this AI tool?
Does the tool solve a real business problem, or is it a feature looking for a use case?
What data does it touch, where does it go, and what new exposure does it create?
Licensing is only part of the cost. We assess rollout, training, integration and operating impact.
Most AI buying decisions start after the demo. That is too late.
AI demos are designed to make the tool look simple, powerful and inevitable. But the real decision is not whether the demo works. It is whether the tool fits your business, data, systems, risk appetite and operating model.
Once budget is committed and stakeholders are excited, it becomes harder to challenge the fundamentals: ownership, adoption, data exposure, integration, contractual terms and measurable value.
An independent AI Tool Evaluation gives you a clear view before you sign, renew or roll out.
A good demo is not a business case.
The tool still needs a clear use case, measurable outcome and accountable owner.
AI features change your risk profile.
Data handling, permissions, vendor terms, auditability and human review need checking.
The license price is not the full cost.
Rollout, integration, training, governance and failed adoption can cost more than the subscription.
One tool review. Five buying checks.
A structured evaluation designed to help leadership decide whether the AI tool is worth buying, delaying, negotiating or rejecting.
Included in the package
AI Tool Evaluation
Independent review of the tool’s business fit, security exposure, integration reality, commercial value and implementation risk.
Use case and business fit
Does the tool solve a real problem, support a defined process, and deliver a measurable business outcome?
Data and security review
What data does the tool access, process or store, and what risks does that introduce?
Integration and rollout reality
How will the tool fit into current systems, workflows, user behaviour and operational ownership?
Commercial and contract view
A practical view of cost, licensing, lock-in, renewal risk, implementation effort and hidden operational cost.
Recommendation and negotiation points
Clear guidance on whether to buy, delay, pilot, negotiate terms or reject the tool.
From vendor pitch to informed buying decision.
The review gives you an independent view before you commit budget, sign terms or roll the tool out across the business.
Clarify the buying decision
We identify what tool is being considered, why, who will use it, and what outcome the business expects.
Review fit, risk and implementation
We assess business fit, data use, security, integration, user adoption, operating impact and governance requirements.
Check commercial and vendor terms
We review licensing, cost model, lock-in, renewal risk, contractual assumptions and implementation obligations.
Recommend buy, wait, negotiate or reject
You receive a clear recommendation and a practical list of conditions, negotiation points or next steps.
A good fit before budget, rollout or renewal.
Good fit if…
Not the right fit if…
From vendor-led excitement to a controlled buying decision.
A promising tool, unclear implications.
Clear recommendation and buying conditions.
Buying AI needs technology, risk and commercial judgement.
Cigma brings together CTO-level technical judgement, CISO-level risk thinking and practical implementation experience. That means the tool is assessed against how it will actually work in the business — not just how it looks in a demo.
Independent
No vendor commission or referral incentive.
Security-aware
Data, access, privacy and vendor risk reviewed.
Implementation-led
Rollout, integration and adoption considered early.
Commercial
Value, cost and decision conditions made clear.
Questions before you buy.
Yes. The review can assess one preferred tool or compare multiple options against business fit, risk, integration, cost and implementation effort.
No. The evaluation is independent and vendor-neutral. The recommendation is based on business fit, risk and value.
That is usually the best time. The review is most valuable before budget is approved, terms are signed, or internal momentum makes the decision difficult to challenge.
Yes. Depending on the outcome, Cigma can support negotiation points, governance, implementation planning, rollout, integration or pilot design.
Next step
Get an independent view before you sign, renew or roll out.
Book a short call. We’ll discuss the tool, the decision you are facing, the risks to check, and whether an AI Tool Evaluation is the right next step.
You will know